Lineage Cell Therapeutics Inc (LCTX)

[DeepDive]

The investment Thesis with BioTime is that this innovative leader in the field of Stem Cell Regenerative Medicine will continue developing and bringing to market innovative therapy after therapy for unmet conditions and diseases, centered around age and cell failure to correct or regenerate.
In the near future we are talking about the wrapping up of preparations to market and marketing of Renevia and Oncocyte cancer Blood tests. Then we have RPE cell therapy studies progressing nicely. Then – the main problem with BTX management is to choose what to develop. It’s a whole blue and empty ocean for them to enter.
Even the short term is 6 months at minimum, and even after launch, months will pass before the full commercial significance is visible.
But there is a high probability that within 5 years, we will own a profitable business spinning off / generating a massive host of regenerative medicine therapy.
With biotech things take time and then, one day – Boom, the valuation reflects the assets the business possesses.
Probably not a good idea to try trade this one, other than buying below 3$ and selling above 4.5$
Read prior posts to get a handle on the business.
Good luck.